CD8A and cancer: MDSCs represent a heterogeneous population of CD11b+Ly6C+Ly6G+ myeloid cells recruited to sites of cancer growth, where they exert immunosuppressive functions, including suppression of CD8+ cytotoxic T cell (CTL) and Treg recruitment29.